Device |
transcatheter septal occluder (atrial) |
Definition |
For the treatment of defects in the atrial septum and closure of atrial septal defects via transcatheter technique. |
Physical State |
permanent implant placed in septum (usually constructed of a combination of metals/polymers that is placed via a venous catheter system) |
Technical Method |
percutaneous venous puncture and interventional technique |
Target Area |
cardiac atrial septum |
Review Panel |
Cardiovascular |
Product Code | OZG |
Premarket Review |
Office of Cardiovascular Devices
(OHT2)
Circulatory Support, Structural and Vascular Devices
(DHT2B)
|
Submission Type |
PMA
|
Device Class |
3
|
Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
Implanted Device? |
Yes
|
Life-Sustain/Support Device? |
No
|
Recognized Consensus Standard
|
Third Party Review |
Not Third Party Eligible |